<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01055860</url>
  </required_header>
  <id_info>
    <org_study_id>R09-02-007</org_study_id>
    <nct_id>NCT01055860</nct_id>
  </id_info>
  <brief_title>One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review</brief_title>
  <official_title>One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlantic Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atlantic Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Robotic approach to sacral colpopexy is a relatively new procedure. The literature is scarce
      in regard to its long-term outcomes. This advanced procedure is offered at MMH through the
      Urogynecology division. The Investigators setup to review the one year outcome of patients
      who underwent this procedure using a polypropylene mesh. These outcomes will include
      anatomical and quality of life measures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>1. Objective anatomic outcomes We will use the pelvic organ prolapse quantification system (POP-Q). Objective surgical failure will be defined as any prolapse at or beyond the introitus</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>2. Prolapse Specific Quality of Life Patients will complete a prolapse specific quality of life instrument prior to and one year after surgery. (PFIQ-7)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3. Pelvic organ prolapse related symptoms (PFDI-20)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4. Graft-related complications Rates of graft erosion into adjacent organs such as bowel, bladder or vagina - during the study period will be reported.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Robotic sacral colpopexy</arm_group_label>
    <description>Our study population will be women who underwent Robotic assisted laparoscopic sacral colpopexy at the Morristown Memorial Hospital for correction of pelvic organ prolapse using a synthetic polypropylene mesh.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Our study population will be women who underwent Robotic assisted laparoscopic sacral
        colpopexy at the Morristown Memorial Hospital for correction of pelvic organ prolapse using
        a synthetic polypropylene mesh.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any Robotic assisted laparoscopic sacral colpopexy with polypropylene mesh during the
             study period

        Exclusion Criteria:

          -  Other graft material than polypropylene.

          -  Enrollment in a different study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Culligan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atlantic Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Atlantic Health Urogynecology</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2010</study_first_submitted>
  <study_first_submitted_qc>January 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2010</study_first_posted>
  <last_update_submitted>March 21, 2011</last_update_submitted>
  <last_update_submitted_qc>March 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Patrick Culligan, MD</name_title>
    <organization>Atlantic Health System</organization>
  </responsible_party>
  <keyword>uterine Prolapse</keyword>
  <keyword>vaginal prolapse</keyword>
  <keyword>mesh erosion</keyword>
  <keyword>urinary incontinence</keyword>
  <keyword>bowel symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

